Features
Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices offer...
While immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that...
Nicola Redfern discusses her career aspirations as she moved through major industry players like Novartis, Sanofi, MSD and Celgene, her leap to...
Dr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends she was...
On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine....
Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique challenges? Matt Fellows speaks...
As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit...
Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following the Supreme Court...
Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as we slowly...
Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of accurate diagnosis. She...